Q² Solutions Welcomes Michael Brown as Immunoanalytical Scientific Director and Site Lead
By Default Author
Q² Solutions Expands Genomics Capabilities in China
By Default Author
Q² Solutions Expands Bioanalytical Capabilities in China
By Default Author
Q² Solutions Partners with NanoString to Market Digital Spatial Profiling Service
By Default Author
Q² Solutions | EA Genomics expands its Immuno-Oncology biomarker assay portfolio to include Tumor Mutational Burden, Microsatellite Instability and T Cell Receptor Sequencing assays
By Default Author
Q² Solutions Enhances Companion Diagnostics Capabilities in Collaboration with Illumina
By Default Author
Q² Solutions Receives 2016 Global Supplier Award from Eli Lilly and Company
By Default Author
Quintiles and Quest Diagnostics Launch Q² Solutions
By Default Author